Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
52,271,711
-
Share change
-
+87,218
-
Total reported value
-
$856,719,315
-
Put/Call ratio
-
88%
-
Price per share
-
$16.39
-
Number of holders
-
142
-
Value change
-
+$346,011
-
Number of buys
-
66
-
Number of sells
-
73
Institutional Holders of DECIPHERA PHARMACEUTICALS IN - COM (DCPH) as of Q4 2022
As of 31 Dec 2022,
DECIPHERA PHARMACEUTICALS IN - COM (DCPH) was held by
142 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,271,711 shares.
The largest 10 holders included
BlackRock Inc., ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, Redmile Group, LLC, STATE STREET CORP, BRAIDWELL LP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), GOLDMAN SACHS GROUP INC, WOLVERINE TRADING, LLC, and Polar Capital Holdings Plc.
This page lists
142
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.